Applied Clinical Trials
August 01, 2015
News
24
8
The "Cures" bill and PDUFA IV are the latest measures pushing for more systematic inclusion of patient views into drug development.
August 01, 2015
News
24
8
August 01, 2015
Clinical Trial Insights
24
8
While still early days, key metrics can be collected in three broad areas
August 01, 2015
View from Brussels
24
8
Officials tackle such areas as early diagnosis and treatment, patient access, and personalized medicine
August 01, 2015
A Closing Thought
24
8
Combining PRO data with clinical feasibility data can make a difference in diabetes care.
August 01, 2015
News
24
8
The number of site audits performed has grown significantly.
August 01, 2015
Feature Article
24
8
The four essential steps to ensuring optimal clinical deliverable specifications and process controls.
August 01, 2015
Feature Article
24
8
How to satisfy regulatory concerns about EDC data integrity and site controls over its source records.
August 01, 2015
Feature Article
24
8
Whether we are referring to CSRs or to IPD, the personal information of trial participants needs to be de-identified prior to release. This article will describe the available methods for de-identifying clinical trial data, and the relative strengths and weaknesses of each.
August 01, 2015
Issue PDF
24
8
CRO/Sponsor: Logical Sourcing: Key Steps Clinical Technology: eSource Record-Keeping Data Sharing: De-identifying Trial Data Also in this issue: R&D Focal Points in Europe Patient Centricity: The Clinical Investment PRO Plusses for Diabetes Research